Evidence map›Paper›PMID 22084328›Full record

ArticlePediatrics2011

Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine.

Margaret M Cortese, Julie Leblanc, Karen E White, Robert C Jerris, Patricia Stinchfield, Kenan L Preston, James Meek, Lynda Odofin, Saadia Khizer, Claudia A Miller and 5 more

Abstract read
In one paragraph

Article in Pediatrics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  11. Article
  12. Article
  13. Rotavirus vaccines in routine use.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Review
  14. Review
  15. Article
  16. Rotavirus vaccines: current status and future considerations.Human vaccines & immunotherapeutics · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Margaret M CorteseCenters for Disease Control and Prevention, Atlanta, GA, USA. mcortese@cdc.gov
Julie Leblanc
Karen E White
Robert C Jerris
Patricia Stinchfield
Kenan L Preston
James Meek
Lynda Odofin
Saadia Khizer
Claudia A Miller
Vicki Buttery
Slavica Mijatovic-Rustempasic
Jamie Lewis
Umesh D Parashar
Lilly Cheng Immergluck

Funding

Emerging Infections Programs-ARRA-HAIU01CI000313 · CI · MINNESOTA STATE DEPT OF HEALTH · PI DANILA, RICHARD NORMAN · 2005 to 2011
$19.6M
DVD&DBD Rotavirus/PCV (ACA) EIPU01CI000307 · CI · CONNECTICUT STATE DEPT OF PUBLIC HEALTH · PI CARTTER, MATTHEW LEWIS · 2005 to 2011
$19.3M
Emerging Infections Program DBD Rotavirus/PCV (ACA) U01CI000312 · CI · GEORGIA STATE DEPARTMENTOF PUBLIC HEALTH · PI TOBIN-D'ANGELO, MELISSA · 2005 to 2011
$13.6M
Renewal Application for Clinical Research Education and Career Development (CRECDR25RR017694 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI OFILI, ELIZABETH O. · 2002 to 2011
$5.5M
NCPDCID CDC HHS U01 CI000307NCPDCID CDC HHS U01CI000307NCPDCID CDC HHS U01 CI000312NCPDCID CDC HHS U01CI000312NCPDCID CDC HHS U01 CI000313NCPDCID CDC HHS U01CI000313NCRR NIH HHS R25 RR017694PHS HHS 200-2009-M-30724
6 · The paper itself

Abstract

objectiveElectronic immunization information systems (IISs) are now established in almost all US states. We used the IIS in Minnesota, Georgia, and Connecticut for immunization data and as the source of 1 of 2 control groups to measure pentavalent rotavirus vaccine (RV5) effectiveness (VE) using case-control methodology. PATIENTS AND

methodsCase-subjects were vaccine-eligible children who presented to 1 of 5 hospitals or emergency departments with gastroenteritis and had rotavirus antigen detected in stool during any of 3 rotavirus seasons (2007-2009). Two control groups were used: children with gastroenteritis who tested negative for rotavirus and children from the IIS matched by zip code and birth date. In Minnesota and Georgia, immunization records for rotavirus-positive and -negative children were also obtained from providers.

resultsOverall, 402 (96%) rotavirus case-subjects and 825 (97%) rotavirus-negative controls who met eligibility criteria were found in the IISs. Ten IIS controls were identified for each case. VE estimates for RV5 were similar across control groups, immunization data sources, and states. VE point estimates for 3 vs 0 doses were 89% to 94% among children aged 8 months or older and 86% to 92% among those aged 24 months or older. VE for 2 doses was ≥90% among children aged 8 months or older, and VE for 1 dose was 66% among those aged 6 weeks through 5 months.

conclusionsThree RV5 doses confer sustained protection against rotavirus disease during the first 3 years of life in US children. Two RV5 doses also seem to provide good protection. IISs can be valuable tools for assessing the effectiveness of vaccines administered to young children.

Indexed as

Information SystemsCase-Control StudiesChild, PreschoolConnecticutGastroenteritisGeorgiaHumansInfantMinnesotaRetrospective StudiesRotavirus InfectionsRotavirus VaccinesRotavirus Vaccines

Identifiers

PMID22084328
PMCPMC8202521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.